Trimethobenzamide

DRUG2 trials

Sponsors

MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals, Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Conditions

AkinesiaDelayed Levodopa OnsetHealthy VolunteersHypomobilityMotor SymptomsParkinson's Disease

Phase 4

Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)

CompletedNCT01770145

MDD US Operations, LLC a subsidiary of Supernus PharmaceuticalsAkinesia, Delayed Levodopa Onset, Hypomobility +2

Start: 2012-12-31End: 2014-04-30Updated: 2023-08-14

Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers

Not yet recruitingNCT07681076

Karuna Therapeutics, Inc., a Bristol Myers Squibb companyHealthy Volunteers

Start: 2026-08-03End: 2026-11-30Target: 225Updated: 2026-07-02